Netherlands· NL-8ddcb995567c
Vyvgart 400 mg, concentraat voor oplossing voor infusie
A selective immunosuppressants product containing efgartigimod alfa, registered in Netherlands by argenx BVBA. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 5 of 19 countries.
Countries holding a registration under ATC L04AA (selective immunosuppressants), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 2 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AA
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- EFGARTIGIMOD ALFA
- Manufacturer
- argenx BVBA
- Country
- Netherlands (NL)
- ATC code
- L04AA
- ATC class
- Selective immunosuppressants
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1674
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplieargenx Switzerland SA
- CzechiaVYVGARTargenx BV, Gent
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
- FinlandVyvgartArgenx
- FranceVYVGART 1 000 mg, solution injectable en seringue préremplieARGENX (BELGIQUE)
- SwedenVyvgart 1000 mg Injektionsvätska, lösningArgenx
- BelgiumVyvgart 1000 mgArgenx
- PolandVyvgartargenx BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9966ea6a-67b1-482c-854f-1570d5f91140 GET /v1/drugs/9966ea6a-67b1-482c-854f-1570d5f91140?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vyvgart-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Selective Immunosuppressants",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128778",
"excipients": [
"ARGININEHYDROCHLORIDE, (L-)",
"HISTIDINE, (L-)",
"HISTIDINEMONOHYDROCHLORIDE 1-WATER (L-)",
"METHIONINE, (L-)",
"NATRIUMCHLORIDE",
"POLYSORBAAT 80 (E 433)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"EFGARTIGIMOD ALFA"
],
"leaflet_url": null,
"authorised_at": "2022/08/10",
"procedure_number": "EMEA/H/C/005849",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1674",
"additional_monitoring": "N"
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.